Prasad G. Kamble
AstraZeneca R&D
Moelndal, O, Sweden
Moelndal, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
AZD2693, a PNPLA3 antisense oligonucleotide, for the treatment of MASH in 148M homozygous participants: Two randomized phase I trials.
Journal: Journal of hepatology
Published: August 20, 2024
CABLES1 expression is reduced in human subcutaneous adipose tissue in obesity and type 2 diabetes but may not directly impact adipocyte glucose and lipid metabolism.
Journal: Adipocyte
Published: August 09, 2023
Palmitate impairs circadian transcriptomics in muscle cells through histone modification of enhancers.
Journal: Life science alliance
Published: July 12, 2022
CDKN2C expression in adipose tissue is reduced in type II diabetes and central obesity: impact on adipocyte differentiation and lipid storage?
Journal: Translational research : the journal of laboratory and clinical medicine
Published: August 17, 2021
Role of Estrogen and Its Receptors in Adipose Tissue Glucose Metabolism in Pre- and Postmenopausal Women.
Journal: The Journal of clinical endocrinology and metabolism
Published: June 10, 2021
Human adipose tissue gene expression of solute carrier family 19 member 3 (SLC19A3); relation to obesity and weight-loss.
Journal: Obesity science & practice
Published: March 02, 2021
Time Course of Metabolic, Neuroendocrine, and Adipose Effects During 2 Years of Follow-up After Gastric Bypass in Patients With Type 2 Diabetes.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 13, 2021
Changes in Circulating Cytokines and Adipokines After RYGB in Patients with and without Type 2 Diabetes.
Journal: Obesity (Silver Spring, Md.)
Published: July 16, 2020
Proof-of-concept for CRISPR/Cas9 gene editing in human preadipocytes: Deletion of FKBP5 and PPARG and effects on adipocyte differentiation and metabolism.
Journal: Scientific reports
Published: February 05, 2020
Last Updated: 09/26/2026